共 50 条
- [41] PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremiaAIDS, 2012, 26 (09) : 1065 - 1071Tendeiro, RitaFoxall, Russell B.Baptista, Antonio P.Pinto, FranciscoSoares, Rui S.Cavaleiro, RitaValadas, EmiliaGomes, PerpetuaVictorino, Rui M. M.Sousa, Ana E.
- [42] Medical image computing to assess tumor infiltrating CD8 T cells, tumor immune phenotype and response to anti-PD-1/PD-L1 immunotherapy in prospective phase 1 trials.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Sun, RogerLimkin, Elaine JohannaVakalopoulou, MariaDercle, LaurentChampiat, StephaneHan, Shan RongVerlingue, LoicBrandao, DavidAmmari, SamyMahjoubi, LindaHollebecque, AntoineScoazec, Jean-YvesMarabelle, AurelienMassard, ChristopheSoria, Jean-CharlesRobert, CharlotteParagios, NikosDeutsch, EricFerte, Charles
- [43] Blockade of PD-L1/CD80 Interactions Augments Function of Activated Donor T Cells Results in Augmenting Gvhd Induced By Donor Naive CD8+t Cells and GVL Effect Mediated By Donor Memory CD8+T CellsBLOOD, 2023, 142Song, QingxiaoZhang, YuankunCassady, KanielLi, QinjianMartin, Paul J.Zeng, Defu
- [44] Targeting HER2-specific CD4+ TH1 cells to tumors to induce CD8+ T cell-mediated tumor rejectionJOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 859 - 860Phan, VyGad, EkramSaddoughi, SaharWaisman, Zachary B.DeLong, Jonathan H.Disis, Mary L.
- [45] Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cellsNature Communications, 14Siqi LiKun LiKang WangHaoyuan YuXiangyang WangMengchen ShiZhixing LiangZhou YangYongwei HuYang LiWei LiuHua LiShuqun ChengLinsen YeYang Yang
- [46] Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cellsNATURE COMMUNICATIONS, 2023, 14 (01)Li, SiqiLi, KunWang, KangYu, HaoyuanWang, XiangyangShi, MengchenLiang, ZhixingYang, ZhouHu, YongweiLi, YangLiu, WeiLi, HuaCheng, ShuqunYe, LinsenYang, Yang
- [47] Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade ImmunotherapyJOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 521 - 532Wu, Si-PeiLiao, Ri-QiangTu, Hai-YanWang, Wen-JunDong, Zhong-YiHuang, Shu-MeiGuo, Wei-BangGou, Lan-YingSun, Hui-WenZhang, QiXie, ZhiYan, Li-XuSu, JianYang, Jin-JiZhong, Wen-ZhaoZhang, Xu-ChaoWu, Yi-Long
- [48] PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells (vol 194, pg 5801, 2015)JOURNAL OF IMMUNOLOGY, 2015, 195 (12): : 5841 - 5842Park, H. J.Park, J. S.Jeong, Y. H.Son, J.Ban, Y. H.Lee, B. -H.Chen, L.Chang, J.Chung, D. H.Choi, I.Ha, S. -J.
- [49] circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3/m6A/PD-L1 mannerCANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (07)Zhang, ZhilingHuo, WenjieLi, Jie
- [50] Single-cell analysis reveals clonally expanded CD57+CD8 T cells in periphery are associated with response to PD-L1 blockade in bladder cancer patientsCANCER RESEARCH, 2022, 82 (12)Yadav, MaheshFehlings, MichaelKim, LeesunGuan, XiangnanYuen, Kobe C.Tafazzol, AlirezaRishipathak, DeepaliSanjabi, ShomyeshWallace, AndrewNardin, AlessandraMa, SimingMilojkovic, AnaNewell, EvanMariathasan, Sanjeev